At Coverings, an event dedicated to stone and tile in Orlando, Florida, The Architect’s Newspaper will present a special edition of the Facades+ conference series. Facades+ Orlando features four ...

BCC is new territory for cancer immunotherapies however, and Libtayo is the first drug in the PD-1/PD-L1 inhibitor class to get go-ahead in this common form of skin cancer. It's been cleared for ...

College of Optoelectronic Engineering, Chongqing University of Posts and Telecommunications, Chongqing 400065, China ...